For Advancing Canine Cancer Treatment with Immunotherapy

Apply For Grants

Will augment the dogs immune response to cancer as an alternative to more aggressive treatments and can maintain their quality of life

Why Immunotherapy?

Our foundation is dedicated to exploring a new frontier in canine cancer treatment

Benefits of Immunotherapy

Immunotherapy can provide an alternative to more aggressive treatments like chemotherapy and radiation.

Benefits of Immunotherapy

Immunotherapy can provide an alternative to more aggressive treatments like chemotherapy and radiation.

Benefits of Immunotherapy

Immunotherapy can provide an alternative to more aggressive treatments like chemotherapy and radiation.

The Challenge

Exploring a New Frontier in Canine Cancer Treatement

Learn More

Cancer research in dogs and in particular research on immunotherapy lags behind human advancements largely due to less funding

Cancer research in dogs and in particular research on immunotherapy lags behind human advancements largely due to less funding

Cancer research in dogs and in particular research on immunotherapy lags behind human advancements largely due to less funding

Cancer research in dogs and in particular research on immunotherapy lags behind human advancements largely due to less funding

Foundation Mission

Identify and support the development of therapeutic options for dogs with cancer that are innovative, have limited side effects and will prolong life

Research Funding & Focus

Research proposals that are designed to make an impact on how canine cancer can be treated are encouraged. Since many conventional cancer therapies (chemotherapy, radiation) suppress and paralyze the dog's immune response to the cancer, the focus of the Foundation's funding is on projects that can strengthen the dog's immune cells to fight the cancer. Many immune treatments that work for human cancer patients could be used for dogs as well but they have never been considered or tested in a scientific manner.

Research Funding & Focus

Research proposals that are designed to make an impact on how canine cancer can be treated are encouraged. Since many conventional cancer therapies (chemotherapy, radiation) suppress and paralyze the dog's immune response to the cancer, the focus of the Foundation's funding is on projects that can strengthen the dog's immune cells to fight the cancer. Many immune treatments that work for human cancer patients could be used for dogs as well but they have never been considered or tested in a scientific manner.

Research Funding & Focus

Research proposals that are designed to make an impact on how canine cancer can be treated are encouraged. Since many conventional cancer therapies (chemotherapy, radiation) suppress and paralyze the dog's immune response to the cancer, the focus of the Foundation's funding is on projects that can strengthen the dog's immune cells to fight the cancer. Many immune treatments that work for human cancer patients could be used for dogs as well but they have never been considered or tested in a scientific manner.

Research Highlights

Explore the latest breakthroughs and advancements in canine cancer immunotherapy.

Explore our Research
Cancer’s Impact on Older Dogs

Nearly half of dogs over ten years old are affected by cancer, making it the leading cause of death among them.

Cancer’s Impact on Older Dogs

Nearly half of dogs over ten years old are affected by cancer, making it the leading cause of death among them.

Cancer’s Impact on Older Dogs

Nearly half of dogs over ten years old are affected by cancer, making it the leading cause of death among them.

Cancer’s Impact on Older Dogs

Nearly half of dogs over ten years old are affected by cancer, making it the leading cause of death among them.

Grant Application

The Lee-Klingemann Canine Cancer Research Foundation funds research in immunotherapy for canine cancer, focusing on effective, safe, and affordable treatments that prolong life of the dog and maintain the quality of the remaining time. We invite applications from diverse researchers, prioritizing pre-clinical projects with potential for clinical development. Studies using human immune-reactive proteins to boost canine immune cells are also welcome.

Apply for Grants

1

Letter of Intent

Deadline • Mar 1st - Sept 1st

  • Submit a one-page summary with a description of the proposed project
  • Selected applicants will be invited for a Zoom discussion.

2

Letter of Intent

Deadline • Mar 1st - Sept 1st

  • Submit a one-page summary with a description of the proposed project
  • Selected applicants will be invited for a Zoom discussion.

3

Letter of Intent

Deadline • Mar 1st - Sept 1st

  • Submit a one-page summary with a description of the proposed project
  • Selected applicants will be invited for a Zoom discussion.